Clinicopathological and Prognostic Value of Gastric Carcinoma Highly Expressed Transcript 1 in Cancer: A Meta-Analysis

Table 2

Survival data of studies included in the meta-analysis.

Study	Year	Country	Tumor type	Sample size	Method	Overall survival (OS)	Cutoff value	NOS
Guan et al. [17]	2018	China	NSCLC	52	Multivariate	2.488(1.415–3.841)	Median	7
Jin et al. [18]	2017	China	HCC	68	Multivariate	7.64(2.28–25.65)	Mean	8
Li et al. [19]	2014	China	BC	80	Multivariate	2.59(1.27–5.25)	Median	7
Liu et al. [20]	2017	China	ESCC	55	NA	NA	Median	7
Liu and Wu [21]	2018	China	HNC	86	Multivariate	2.21(1.25–3.89)	Median	8
Shen et al. [22]	2018	China	NSCLC	105	Multivariate	2.20(1.38–3.51)	Median	7
Song et al. [23]	2018	China	BRC	60	Multivariate	1.92(1.06–3.49)	Median	8
Xia et al. [24]	2018	China	GC	42	NA	NA	Median	7
Yang et al. [11]	2014	China	GC	42	Multivariate	1.88(1.03–3.42)	Median	8
Yang et al. [25]	2018	China	OSC	60	Multivariate	2.14(1.13–4.05)	—	7
Zhou et al. [26]	2017	China	PC	64	NA	NA	Median	7

Note. NA represent no data. NSCLC, non-small-cell lung cancer; HCC, hepatocellular carcinoma; BC, bladder cancer; ESCC, esophageal squamous cell carcinoma; HNC, head and neck cancer; BRC, breast cancer; GC, gastric cancer; OSC, osteosarcoma; PC, pancreatic cancer; OS, overall survival; NOS, Newcastle–Ottawa scale.